Publication | Closed Access

Adjustment of therapeutic LMWH to achieve specific target anti-FXa activity does not affect outcomes in pregnant patients with venous thromboembolism

ThrombosisVenous ThrombosisMaternal Cardiovascular OutcomeMedicineHematologyMaternal HealthPharmacotherapyCoagulopathyVenous ThromboembolismPlatelet AntagonistPharmacologyAnticoagulantPregnant PatientsTherapeutic Lmwh